US › Healthcare

Tela Bio Inc (TELA)

US · Healthcare · Medical Devices

$0.91+22.51%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$19.1M
Revenue YoY
+2.9%
Net profit
$-12.3M
Profit YoY
-9.0%
EPS
$-0.21
EPS estimate
$-0.15
Net margin
-64.4%

EPS came in at -0.21 against a street estimate of -0.15 — a miss of 39.9%.

Key statistics

Market cap
$33.1M
Forward P/E
0.0
P/B
7.30
Book value
$-0.12
EPS (TTM)
$-0.79
52-week high
$2.14
52-week low
$0.50
50-day MA
$0.81
200-day MA
$0.94
Beta
1.36

Analyst view

Analysts rate Tela Bio Inc a buy (4 buy, 1 hold, 0 sell out of 5) with an average price target of $2.25.

Shareholding

Insiders
7.71%
Institutions
68.98%

Largest institutional holders

FundStake
Essex Woodlands Health Ventures17.23%
Nantahala Capital Management, LLC11.49%
Stonepine Capital Management Llc5.85%
SILVERARC CAPITAL MANAGEMENT, LLC5.05%
Vanguard Capital Management, LLC3.44%
Dafna Capital Management LLC3.22%
Perkins Capital Management Inc3.17%
UBS Group AG2.37%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Tela Bio Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.